Beta2-microglobulin as a diagnostic marker in cerebrospinal fluid: A follow-up study

Disease Markers

Volumn 2014, Issue , 2014, Pages

  Svatoňová, Jana ^a   Bořecká, Klára ^b   Adam, Pavel ^c,d   Lánská, Věra ^e  

^a RHG City Hospital   (Czech Republic)

^b FAKULTNÍ THOMAYEROVA NEMOCNICE   (Czech Republic)

^c CENTRAL MILITARY HOSPITAL   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

^e INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; GLUCOSE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LACTIC ACID; PROTEIN; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL MENINGITIS; BORRELIA INFECTION; BRAIN TUMOR; CELL COUNT; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID CYTOLOGY; CHILD; CONTROLLED STUDY; FOLLOW UP; HUMAN; INFLAMMATION; ISOELECTRIC FOCUSING; MAJOR CLINICAL STUDY; MENINGEAL METASTASIS; MULTIPLE SCLEROSIS; NEURITIS; NEUROBORRELIOSIS; NEUROLOGIC DISEASE; POLYNEUROPATHY; TURBIDIMETRY; VIRUS ENCEPHALITIS; VIRUS MENINGITIS; BORRELIA INFECTIONS; CASE CONTROL STUDY; MENINGEAL NEOPLASMS; MENINGITIS, BACTERIAL; MIDDLE AGED; PRESCHOOL CHILD; SECONDARY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; BORRELIA INFECTIONS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; HUMANS; MENINGEAL NEOPLASMS; MENINGITIS, BACTERIAL; MENINGITIS, VIRAL; MIDDLE AGED; MULTIPLE SCLEROSIS; YOUNG ADULT;

EID: 84901815833     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2014/495402     Document Type: Article

References (41)

1. 2-microglobulin. Proceedings of the National Academy of Sciences of the United States of America 1985 82 12 4225 4229 2-s2.0-0011039325
2. 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors. Proceedings of the National Academy of Sciences of the United States of America 1994 91 11 4751 4755 2-s2.0-0028180967 10.1073/pnas.91.11.4751 (Pubitemid 24177727)
3. Vivian J. P., Duncan R. C., Berry R., O'Connor G. M., Reid H. H., Beddoe T., Gras S., Saunders P. M., Olshina M. A., Widjaja J. M. L., Harpur C. M., Lin J., Maloveste S. M., Price D. A., Lafont B. A. P., McVicar D. W., Clements C. S., Brooks A. G., Rossjohn J., Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature 2011 479 7373 401 405 2-s2.0-81555213587 10.1038/nature10517
4. Lu X., Gibbs J. S., Hickman H. D., David A., Dolan B. P., Jin Y., Kranz D. M., Bennink J. R., Yewdell J. W., Varma R., Endogenous viral antigen processing generates peptide-specific MHC class I cell-surface clusters. Proceedings of the National Academy of Sciences of the United States of America 2012 109 38 15407 15412
5. Guder W. G., Hofmann W., Clinical role of urinary low molecular weight proteins: their diagnostic and prognostic implications. Scandinavian Journal of Clinical and Laboratory Investigation 2008 68 241 95 98 2-s2.0-45849106086 10.1080/00365510802150174 (Pubitemid 351883666)
6. Lemancewicz D., Bolkun L., Jablonska E., Czeczuga-Semeniuk E., Kostur A., Kloczko J., Dzieciol J., The role of interleukin-17A and interleukin-17E in multiple myeloma patients. Medical Science Monitor 2012 18 1 BR54 BR59 2-s2.0-84855282454
7. Olsen N. J., Li Q. Z., Quan J., Wang L., Mutwally A., Karp D. R., Autoantibody profiling to follow evolution of lupus syndromes. Arthritis Research & Therapy 2012 14 R174
8. Duek A., Shvidel L., Braester A., Berrebi A., Clinical and Immunologic aspects of B chronic lymphocytic leukemia associated with autoimmune disorders. Israel Medical Association Journal 2006 8 12 828 831 2-s2.0-33845879592 (Pubitemid 46017761)
9. Kwon H.-K., Pyun S.-B., Cho W. Y., Boo C. S., Carpal tunnel syndrome and peripheral polyneuropathy in patients with end stage kidney disease. Journal of Korean Medical Science 2011 26 9 1227 1230 2-s2.0-80052791267 10.3346/jkms.2011.26.9.1227
10. Neirynck N., Eloot S., Glorieu G., Estimated glomerular filtration rate is a poor predictor of the concentration of middle molecular weight uremic solutes in chronic kidney disease. PLoS ONE 2012 7 8 e44201 10.1371/journal. pone.0044201
11. 2-microglobulin: roles of shear flow, hydrophobic surfaces, and α -crystallin. The Journal of Biological Chemistry 2013 288 43 30917 30930 10.1074/jbc.M113.498857
12. Nolen B. M., Orlichenko L. S., Marrangoni A., An extensive targeted proteomic analysis of disease-related protein biomarkers in urine from healthy donors. PLoS ONE 2013 8 5 e63368 10.1371/journal.pone.0063368
13. de Borst M. H., Nauta F. L., Vogt L., Laverman G. D., Gansevoort R. T., Navis G., Indomethacin reduces glomerular and tubular damage markers but not renal inflammation in chronic kidney disease patients: a post-hoc analysis. PLoS ONE 2012 7 5 e37957 10.1371/journal.pone.0037957
14. Lei L., Chang X., Rentschler G., Tian L., Zhu G., Chen X., Jin T., Broberg K., A polymorphism in metallothionein 1A (MT1A) is associated with cadmium-related excretion of urinary beta2 microglobulin. Toxicology and Applied Pharmacology 2012 265 373 379
15. Peters H. P. E., van den Brand J. A. J. G., Wetzels J. F. M., Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy. Netherlands Journal of Medicine 2009 67 2 54 61 2-s2.0-60849098179
16. Branten A. J. W., Du Buf-Vereijken P. W., Klasen I. S., Bosch F. H., Feith G. W., Hollander D. A., Wetzels J. F., Urinary excretion of β 2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study. Journal of the American Society of Nephrology 2005 16 1 169 174 2-s2.0-21644475372 10.1681/ASN.2004040287 (Pubitemid 43073169)
17. Sobek O., Adam P., Koudelková M., Štourač P., Mareš J., Algoritmus vyšetření likvoru v návaznosti na doporučení Sekce neuroimunologie a likvorologie České neurologické společnosti JEP. [The algorithm of CSF examination according to the recommendation of the Committee of CSF and Neuroimmunology of the Czech Neurological Society]. Česká a Slovenská Neurologie a Neurochirurgie 2012 75 2 159 163
18. Hegen H., Deisenhammer F., Cerebrospinal fluid biomarkers in bacterial meningitis. LaboratoriumsMedizin 2009 33 6 321 331 2-s2.0-73549114859 10.1515/JLM.2009.059
19. Hühmer A. F., Biringer R. G., Amato H., Fonteh A. N., Harrington M. G., Protein analysis in human cerebrospinal fluid: physiological aspects, current progress and future challenges. Disease Markers 2006 22 1-2 3 26 2-s2.0-29244469691 (Pubitemid 41831602)
20. Thompson E. J., Proteins of the Cerebrospinal Fluid: Analysis & Interpretation in the Diagnosis and Treatment of Neurological Disease 2006 Academic Press
21. Kim Y. O., Kang J. S., Youm M. H., Jong Woo Y., Diagnostic capability of CSF ferritin in children with meningitis. Pediatric Neurology 2003 28 4 271 276 2-s2.0-0038351884 10.1016/S0887-8994(02)00625-2 (Pubitemid 36802225)
22. Makoo Z. B., Ahadi N., Hasani A., Makoo R. B., Mashrabi O., Cerebrospinal fluid (CSF) ferritin for differentiation of aseptic and bacterial meningitis in adults. American Journal of Infectious Diseases 2010 6 4 98 102 2-s2.0-79960420040 10.3844/ajidsp.2010.98.102
23. Alarcon A., Garcia-Alix A., Cabañas F., Hernanz A., Pascual-Salcedo D., Martin-Ancel A., Cabrera M., Tagarro A., Quero J., Beta2-microglobulin concentrations in cerebrospinal fluid correlate with neuroimaging findings in newborns with symptomatic congenital cytomegalovirus infection. European Journal of Pediatrics 2006 165 9 636 645 2-s2.0-33746552769 10.1007/s00431-006-0160-x (Pubitemid 44134225)
24. Baquero-Artigao F., Méndez A., Del Castillo F., Velázquez R., Cerebrospinal fluid β -microglobulin values in perinatally acquired cytomegalovirus infection. Pediatric Infectious Disease Journal 2004 23 9 891 892 2-s2.0-6344246027 10.1097/01.inf.0000137576.29119.bb (Pubitemid 40221043)
25. 2-microglobulin in cerebrospinal fluid and diagnosis of neurosyphilis in an affected newborn. Journal of Perinatal Medicine 2005 33 1 79 82 2-s2.0-13844281994 10.1515/JPM.2005.015 (Pubitemid 40254824)
26. Nyamweya S., Townend J., Zaman A., Are plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections? PLoS ONE 2012 7 9 10.1371/journal.pone.0044411
27. Brew B. J., Pemberton L., Blennow K., Wallin A., Hagberg L., CSF amyloid β 42 and tau levels correlate with AIDS dementia complex. Neurology 2005 65 9 1490 1492 2-s2.0-27644524501 10.1212/01.wnl.0000183293.95787.b7 (Pubitemid 41552790)
28. Brew B. J., Halman M., Catalan J., Sacktor N., Price R. W., Brown S., Atkinson H., Clifford D. B., Simpson D., Torres G., Hall C., Power C., Marder K., McArthur J. C., Symonds W., Romero C., Factor in AIDS dementia complex trial design: results and lessons from the abacavir trial. PLoS Clinical Trials 2007 2 3, article e13 2-s2.0-34249815222 10.1371/journal.pctr.0020013 (Pubitemid 46851656)
29. Yilmaz A., Fuchs D., Hagberg L., Nillroth U., Ståhle L., Svensson J.-O., Gisslén M., Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study. BMC Infectious Diseases 2006 6, article 63 2-s2.0-33645789363 10.1186/1471-2334-6-63
30. Cysique L. A., Brew B. J., Halman M., Catalan J., Sacktor N., Price R. W., Brown S., Atkinson J. H., Clifford D. B., Simpson D., Torres G., Hall C., Power C., Marder K., McArthur J. C., Symonds W., Romero C., Undetectable cerebrospinal fluid HIV RNA and β -2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients. Journal of Acquired Immune Deficiency Syndromes 2005 39 4 426 429 2-s2.0-22344436196 10.1097/01.qai.0000165799.59322.f5 (Pubitemid 41003788)
31. Morris K. A., Davies N. W., Brew B. J., A guide to interpretation of neuroimmunological biomarkers in the combined antiretroviral therapy-era of HIV central nervous system disease. Neurobehavioral HIV Medicine 2010 2 59 72
32. Hansson S. F., Puchades M., Blennow K., Sjögren M., Davidsson P., Validation of a prefractionation method followed by two-dimensional electrophoresis-applied to cerebrospinal fluid proteins from frontotemporal dementia patients. Proteome Science 2004 2, article 7 2-s2.0-21044435930 10.1186/1477-5956-2-7 (Pubitemid 41630799)
33. Zhang J., Goodlett D. R., Montine T. J., Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases. Journal of Alzheimer's Disease 2005 8 4 377 386 2-s2.0-33645058671
34. Hunot S., Hirsch E. C., Isacson I., Olanow O., Rascol R., Schapira S., Beal B., Jenner J., Neuroinflammatory processes in Parkinson's disease. Annals of Neurology 2003 53 3 S49 S60 2-s2.0-0037378023 10.1002/ana.10481 (Pubitemid 36368562)
35. Mattsson N., Insel P., Nosheny R., Zetterberg H., Trojanowski J. Q., Shaw L. M., Tosun D., Weiner M., CSF protein biomarkers predicting longitudinal reduction of CSF β -amyloid42 in cognitively healthy elders. Translational Psychiatry 2013 3, article e293 10.1038/tp.2013.69
36. 2 microglobulin in human amniotic fluid. PLoS ONE 2012 7 11 10.1371/journal.pone.0047642
37. Bořecká K., Adam P., Sobek O., Hajduková L., Lánská V., Nekola O., Coefficient of energy balance: effective tool for early differential diagnosis of CNS diseases. BioMed Research International 2013 2013 8 10.1155/2013/745943 745943
38. Reiber H., The hyperbolic function: a mathematical solution of the protein flux/CSF flow model for blood-CSF barrier function. Journal of the Neurological Sciences 1994 126 2 243 245 2-s2.0-43949151945
39. Adam P., Táborský L., Sobek O., Hildebrand T., Kelbich P., Průocha M., Hyánek J., Cerebrospinal fluid. Advances in Clinical Chemistry 2001 36 1 62 2-s2.0-0035236810
40. Felgenhauer K., Thomas L., Laboratory of neurological diseases. Clinical Laboratory Diagnostics. Use and Assessment of Clinical Laboratory Results 1998 Franfurkt, Germany TH-Books Verlagsgesellschaft mbH 1308 1326
41. Seyfert S., Kunzmann V., Schwertfeger N., Koch H. C., Faulstich A., Determinants of lumbar CSF protein concentration. Journal of Neurology 2002 249 8 1021 1026 2-s2.0-0036041572 10.1007/s00415-002-0777-2 (Pubitemid 35002223)